ArticleArquivos de neuro-psiquiatria2026
Erectile dysfunction and lower urinary tract symptoms in men with multiple sclerosis.
Article in Arquivos de neuro-psiquiatria, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system commonly associated with lower urinary tract symptoms (LUTS) and erectile dysfunction (ED); however, these conditions remain underinvestigated in Brazilian populations. Objective: To evaluate the prevalence of ED and LUTS, to analyze the correlations involving the 5-item International Index of Erectile Function (IIEF-5), the International Prostate Symptom Score (IPSS), the Expanded Disability Status Scale (EDSS), age, and disease duration, and to identify the subscale items most strongly associated with neurological disability in men with MS. Methods: We conducted a cross-sectional study enrolling 56 men with MS diagnosed through the McDonald criteria at the Reference Center for MS of the state of Paraíba, Brazil. Erectile dysfunction was assessed using the IIEF-5, and LUTS, using the IPSS. Spearman correlations with Bonferroni correction, univariate linear regression, one-way analysis of variance (ANOVA), and Tukey's Honestly-Significant Difference (HSD) post-hoc tests were performed. Results: The mean age of the sample was 39.9 ± 12.3 years, the median EDSS score, 2.75, and the median disease duration, 7 years. The prevalence of ED was of 50%, and that of LUTS, 96.4%. Strong correlations were found between the scores on the EDSS and the IIEF-5, the EDSS and the IPSS, and the IIEF-5 and the IPSS. Through the analysis, we identified erection confidence and urinary intermittency as the subscale items most strongly associated with the EDSS score. One-way ANOVA revealed significant differences across MS phenotypes for the IIEF-5, IPSS, and EDSS, with Tukey HSD confirming relapsing-remitting MS versus secondary progressive MS as the primary source of divergence. Conclusion: Erectile dysfunction and LUTS were highly-prevalent in men with MS in the cohort of the present study. Disability level was the strongest correlate of both dysfunctions, supporting integrated urological-neurological screening in MS care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.